How US FDA Wants Pharmaceutical Production Volumes Reported For Drug Shortage Prevention
Executive Summary
Monthly data are expected in annual reports on listed drugs and active ingredients from every registered site, starting in February.
You may also be interested in...
Industry Fears Report-Writing Burden From Supply Chain Risk Guidance US FDA Is Drafting
As agency prepares guidance on CARES Act requirement for risk management plans to help prevent shortages of critical medicines, industry raised concerns that a broad interpretation of the “life-saving drugs” term used in the legislation could make compliance challenging.
The Quality Lowdown: What Happens When The US FDA Must Choose Between Risks
Tuberculosis or cancer, sterility assurance or shortages, the choices come at you fast; Takeda, Wintac, Banco Vida updates.
Real-Time Manufacturing Volume Reporting Could Help Prevent Drug Shortages, Woodcock Tells Congress
If the US FDA could track production, it could anticipate shortages – and national security threats from countries like China.